Result of Tender Offer

Summary by AI BETAClose X

Maven Renovar VCT PLC announced the results of its Tender Offer, where 11,209,948 Ordinary Shares were validly tendered, representing approximately 8% of the issued shares, for a total return to shareholders of approximately £6,125,327. The purchase price was 54.6419 pence per share, a 3.5% discount to the net asset value per share of 56.6237 pence as of May 22, 2026. Following the completion of the tender offer, the company will have 128,862,062 Ordinary Shares in issue, with no shares held in treasury.

Disclaimer*

Maven Renovar VCT PLC
26 May 2026
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. ON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN. THIS ANNOUNCEMENT HAS BEEN AUTHORISED FOR RELEASE BY THE COMPANY'S BOARD OF DIRECTORS.

This announcement is not an offer to sell, or a solicitation of an offer to acquire, securities in any jurisdiction in which the same would be unlawful. Neither this announcement nor any part of it shall form the basis of or be relied on in connection with or act as an inducement to enter into any contract or commitment whatsoever.

For immediate release

                           26 May 2026

 

Maven Renovar VCT PLC 

Legal Entity Identifier: 213800HAEDBBK9RWCD25

Result of Tender Offer

The Board of Maven Renovar VCT PLC (the "Company") is pleased to announce the result of the Tender Offer, details of which were set out in the circular published by the Company on 27 April 2026 (the "Circular").

The maximum aggregate number of Ordinary Shares that could be purchased pursuant to the Tender Offer was 16,847,339 Ordinary Shares, representing 12 per cent. of the Company's issued Share capital as at 27 April 2026. The Tender Price is 54.6419 pence per Ordinary Share, being a 3.5 per cent. discount to the NAV per Share as at 22 May 2026 of 56.6237 pence (adjusted to add back costs relating to the implementation of the Tender Offer already incurred). In total, 11,209,948 Ordinary Shares were validly tendered, equal to approximately 8 per cent. of the Ordinary Shares in issue as at the Record Date. As the Tender Offer was not fully subscribed, validly tendered Basic Entitlements, and any valid tenders in excess of the Basic Entitlement, will be satisfied in full.

Accordingly, a total of 11,209,948 Ordinary Shares will be purchased under the Tender Offer. The total value which will be returned to Shareholders pursuant to the Tender Offer is approximately £6,125,327.

Payment of the consideration due to Shareholders, whose tenders under the Tender Offer have been accepted, is expected to be paid by no later than 3 June 2026 to both certificated Shareholders and CREST members.

Total Voting Rights

Following completion of the Tender Offer, the Company will have 128,862,062 Ordinary Shares in issue. The Company does not hold any Shares in Treasury. Therefore, the total number of voting rights in the Company will be 128,862,062 and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change of interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Capitalised terms in this announcement (unless otherwise defined) have the same meanings as set out in the Circular.

Enquiries

For further information please contact:

Maven Capital Partners UK LLP, Company Secretary

Tel: 0141 306 7400

Email: CoSec@mavencp.com

Fiona Wollocombe, Chair

Maven Renovar VCT PLC

Email: MavenRenovarVCTChair@mavencp.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings